This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen'
This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen'

This pharma company gets approval to set up a new manufacturing facility for its popular drug 'Ibuprofen'

Shares of the company zoomed on getting CEP approval to manufacture Ibuprofen from the Vishakhapatnam facility.

Tushar Jain Article rating: 4.0

Solara Active Pharma Sciences (Solara) has received ‘Certificate of Suitability (CEP) approval for its new state-of-the-art multipurpose API manufacturing facility at Vishakhapatnam.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR